) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Company Year 31/01/2022 2022 Consolidated Year 31/01/2022 2022 Reviewed Company Q3 31/10/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Company Year 31/01/2022 2022 Consolidated Year 31/01/2022 2022 Reviewed Company Q3 31/10/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Company Year 31/01/2022 2022 Consolidated Year 31/01/2022 2022 Reviewed Company Q3 31/10/2021
Of Details INTER PHARMA PUBLIC COMPANY LIMITED 2021 Consolidated Year 31/12/2021 INTER PHARMA PUBLIC COMPANY LIMITED 2021 Company Year 31/12/2021 INTER PHARMA PUBLIC COMPANY LIMITED 2021 Reviewed
Period As Of Details QUALITECH PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 QUALITECH PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 QUALITECH PUBLIC COMPANY LIMITED 2023
Period As Of Details U CITY PUBLIC COMPANY LIMITED 2022 Reviewed Company Q2 30/06/2022 U CITY PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q2 30/06/2022 U CITY PUBLIC COMPANY LIMITED 2022 Reviewed
Period As Of Details PATKOL PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 PATKOL PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 PATKOL PUBLIC COMPANY LIMITED 2023 Reviewed
“we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the years ended December 31, 2019 as follows
” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the six months period ended Jun 30, 2019
“Company” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the nine months period ended Sep 30